MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Automated DBS Contact Selection using Coherence in Parkinson’s Disease

    J. van Zijl, J. Elting, T. van Laar, F. Lange, G. Drost, D. Oterdoom, J. van Dijk, M. Tijssen, M. Beudel (Groningen, Netherlands)

    Objective: To investigate whether subthalamic nucleus (STN)-EMG coherence can be used to predict the most effective deep brain stimulation (DBS) contact. Background: Although DBS is…
  • 2017 International Congress

    Probabilistic mapping of deep brain stimulation in Parkinson’s disease.

    T. Dembek, J. Roediger, V. Visser-Vandewalle, L. Timmermann, M. Barbe (Cologne, Germany)

    Objective: To find the neuroanatomical origins of deep brain stimulation (DBS) induced effects using probabilistic mapping. Background: While DBS of the subthalamic nucleus (STN) and…
  • 2017 International Congress

    Programming deep brain stimulation in the globus pallidus internus for treatment of idiopathic Parkinson’s disease: experience at the University of Kentucky

    J. Gurwell, J. Quintero, J. Lamm, J. Slevin, G. Gerhardt, C. van Horne (Lexington, KY, USA)

    Objective: To report deep brain stimulation (DBS) programming parameters and experiences in patients with idiopathic Parkinson’s disease (PD) implanted with globus pallidus internus (GPi) leads.…
  • 2017 International Congress

    Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinsons’ disease

    M. Wolf, M. Abdallat, C. Blahak, J. Krauss (Mannheim, Germany)

    Objective: To report on a patient with Parkinsons’ disease (PD) who developed pathologic crying (PC) following chronic deep brain stimulation (DBS) of the subthalamic nucleus…
  • 2017 International Congress

    Evaluation of Patient-Reported Outcomes in Tardive Dyskinesia Patients With Underlying Psychotic and Mood Disorders in the ARM-TD and AIM-TD Trials

    H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, K. Anderson (Cleveland, OH, USA)

    Objective: To assess patients’ impression of treatment benefit from deutetrabenazine (DTB) for the treatment of tardive dyskinesia (TD). Background: In TD, patients’ perception of benefit…
  • 2017 International Congress

    Tardive syndromes induced by coadministration of tramadol and sertralin

    H. Sarac, N. Bozina, N. Henigsberg, L. Bagaric-Krakan (Zagreb, Croatia)

    Objective: To illustrate the possible association of tardive syndromes (TS) and coadministration of tramadol and sertraline in three patients. Background: TS is delayed onset of…
  • 2017 International Congress

    C19orf12 p.Thr11Met mutation is frequent among adult Turkish patients with MPAN

    M. Quadri, S. Olgiati, O. Doğu, Z. Tufekcioglu, Y. Diler, E. Saka, M. Gultekin, H. Kaleagasi, D. Kuipers, J. Graafland, G. Breedveld, R. Sürmeli, G. Sünter, T. Doğan, A.D. Yalçın, B. Bilgiç, B. Elibol, M. Emre, H. Hanagasi, V. Bonifati (Rotterdam, Netherlands)

    Objective: To genetically and clinically characterize a series of Turkish patients affected by neurodegeneration with brain iron accumulation (NBIA) compatible with an autosomal recessive form…
  • 2017 International Congress

    A retrospective analysis of clinical forms and age of onset of biallelic Huntington disease patients from an Argentinean Center

    M. Cesarini, V. Parisi, G. Persi, J. Etcheverry, A. Sanguinetti, F. Squitieri, E. Gatto (Buenos Aires, Argentina)

    Objective: To compare AO and clinical presentation in Argentinean bi-allelic (BHD) patients, ie one mutated allele and one either intermediate (IA, 27-35 CAG repeats) or…
  • 2017 International Congress

    Cerebrospinal fluid biomarkers in Huntington’s disease – a longitudinal study

    V. Niemelä, J. Sundblom, A.-M. Landtblom, S. Herman, K. Kultema, D. Nyholm, K. Blennow (Uppsala, Sweden)

    Objective: To validate the role of NFL as a marker of disease progression and to discover new biomarkers in HD. Background: Neurofilament light chain (NFL)…
  • 2017 International Congress

    Prescription pattern of treatment in Mexican patients with Huntington’s Disease.

    A. De-la-Cruz, L. Mendoza Vega, N. Davila Avila, K. Salinas Barboza, S. Isais Millan, A. Cervantes Arriaga, M. Rodriguez Violante (Ciudad de Mexico, Mexico)

    Objective: To describe the prescription pattern for the treatment of HD in a sample of Mexican patients from a tertiary referral center. Background: Huntington’s disease…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley